Inventor · disambiguated record
Alex Eberlin
Also filed as: EBERLIN ALEX
20 granted patents·12 pending applications·89 citations·filing 2006–2025
94Inventor score
Files withINTERCEPT PHARMACEUTICALS INC12RADIUS PHARMACEUTICALS INC6AMGEN INC2CONDUIT UK MAN LTD2EBERS TECH INC2
Top patents by PatentIndex Score
32 records- 0194US11708318B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·3 cites·18 claims
- 0294US9732116B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·20 cites·10 claims
- 0393US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0493US10385008B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 20, 2019·6 cites·18 claims
- 0592US10745343B2Polymorphic forms of RAD1901-2HClRADIUS PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·5 cites·21 claims
- 0690US11148996B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2020·Granted Oct 19, 2021·2 cites·19 claims
- 0790US9238673B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·12 cites·23 claims
- 0887US12398094B2Polymorphic forms of RAD1901-2HCLRADIUS PHARMACEUTICALS INC·Filed 2023·Granted Aug 26, 2025·0 cites·16 claims
- 0984US2025011360A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1083US2023340010A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1182US9062014B2Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-0-tolyl-thiazolidin-4-oneBONHAM NICHOLAS·Filed 2009·Granted Jun 23, 2015·18 cites·20 claims
- 1281US12319649B1Cannabidiolic acid cocrystalsMANOIRA CORP·Filed 2024·Granted Jun 3, 2025·0 cites·8 claims
- 1381US10047117B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·13 claims
- 1480US11643385B2Polymorphic forms of RAD1901-2HClRADIUS PHARMACEUTICALS INC·Filed 2019·Granted May 9, 2023·1 cites·13 claims
- 1579US7605270B2Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamateVERTEX PHARMA·Filed 2006·Granted Oct 20, 2009·3 cites·10 claims
- 1674US12049452B2Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical useNUFORMIX TECH LIMITED·Filed 2022·Granted Jul 30, 2024·0 cites·33 claims
- 1774US10155787B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·1 cites·15 claims
- 1873US2021395293A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1971US12378227B2Therapeutic cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy)-N-(5-methylpyrazin-2-yl)benzamideCONDUIT UK MAN LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 2071US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 2166US2019153020A1Preparation and Uses of Obeticholic AcidINTERCEPT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2265US10174073B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·0 cites·61 claims
- 2361US2025282763A1Therapeutic cocrystals of 3-{[5-(azetidine-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1s)-1-methyl-2-(methyloxy)ethyl]oxy)-n-(5-methylpyrazin-2-yl)benzamideCONDUIT UK MAN LTD·Filed 2025·Application pending·0 cites
- 2460US12012386B2Olaparib oxalic acid cocrystals and their pharmaceutical useNUFORMIX TECH LIMITED·Filed 2021·Granted Jun 18, 2024·0 cites·12 claims
- 2560US2025236581A1Cannabidiolic acid cocrystalsMANOIRA CORP·Filed 2024·Application pending·0 cites
- 2658US9982008B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·0 cites·14 claims
- 2758US8153668B2Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamateBLYTHE TODD·Filed 2009·Granted Apr 10, 2012·0 cites·4 claims
- 2854US2023183202A1Tetrahydrococannabinolic acid cocrystalsEBERS TECH INC·Filed 2021·Application pending·0 cites
- 2951US2018305397A1Preparation and Uses of Obeticholic AcidINTERCEPT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3049US2022298158A1Polymorph of venetoclax and method for preparing the polymorphJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
- 3144US2022332682A1Caanabigerol proline cocrystalsEBERS TECH INC·Filed 2020·Application pending·0 cites
- 3238US2020024299A1Crystalline forms of a bile acid derivativeINTERCEPT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alex Eberlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →